Position in LLY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$84,569,172
-$200,519 QoQ
Shares Held
91,946
+16.6% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Steward Partners Investment Advisory, LLC holds $457,189,468 across 19 Drug Manufacturers - General names. LLY ranks #3 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
629,201 | $153,801,892 | |
| 2 | ABBV |
AbbVie Inc.
|
436,916 | $95,024,860 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
91,946 | $84,569,172 | |
| 4 | MRK |
Merck & Co., Inc.
|
305,398 | $36,736,325 | |
| 5 | AMGN |
Amgen Inc
|
76,905 | $27,059,024 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
244,135 | $14,806,787 | |
| 7 | PFE |
Pfizer Inc
|
472,519 | $13,268,333 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
75,160 | $10,475,049 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $84,569,172 | 91,946 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $84,769,691 | 78,879 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $57,577,506 | 75,462 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $60,722,268 | 77,896 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $61,787,153 | 74,811 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $55,755,384 | 72,222 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $56,373,248 | 63,631 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $55,145,790 | 60,909 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $48,235,075 | 62,002 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $34,331,073 | 58,895 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $29,807,492 | 55,494 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $28,304,818 | 60,354 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $21,356,602 | 62,188 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $20,659,716 | 56,472 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $17,680,131 | 54,678 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $15,673,602 | 48,341 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $10,350,270 | 36,143 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $9,804,428 | 35,495 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $8,004,727 | 34,645 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,714,185 | 37,967 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,227,787 | 49,394 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,785,263 | 28,342 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,298,204 | 29,038 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $4,433,352 | 27,003 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $3,586,328 | 25,853 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||